IMCOOI
RPRX icon

Investment Management Corp of Ontario (IMCO)’s Royalty Pharma RPRX Stock Holding History

Investment Management Corp of Ontario (IMCO)’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.47M Sell
26,212
-2,800
-10% -$146K 0.02% 487
2026
Q1 		$1.39M Buy
29,012
+1,300
+5% +$56.9K 0.02% 498
2025
Q4 		$1.07M Buy
27,712
+9,856
+55% +$376K 0.01% 554
2025
Q3 		$630K Buy
17,856
+8,823
+98% +$319K 0.01% 564
2025
Q2 		$325K Sell
9,033
-1,600
-15% -$53K ﹤0.01% 589
2025
Q1 		$331K Hold
10,633
– – 0.01% 601
2024
Q4 		$271K Sell
10,633
-2,100
-16% -$55.7K 0.01% 340
2024
Q3 		$360K Buy
12,733
+4,100
+47% +$114K 0.01% 594
2024
Q2 		$228K Buy
+8,633
New +$239K 0.01% 603
2024
Q1 		– Sell
-8,933
Closed -$251K – 666
2023
Q4 		$251K Buy
+8,933
New +$245K 0.01% 613

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Investment Management Corp of Ontario (IMCO)'s RPRX Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its Royalty Pharma (RPRX) stake by 9.7% in Q2 2026, selling an estimated $146K and leaving 26,212 shares worth $1.47M. The position accounts for 0.02% of the portfolio, ranked #487.

Investment Management Corp of Ontario (IMCO) first reported a position in RPRX in Q4 2023 and has held it in 10 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Investment Management Corp of Ontario (IMCO) held 26,212 shares of Royalty Pharma worth $1.47M as of Q2 2026.
  • Investment Management Corp of Ontario (IMCO) sold 2,800 Royalty Pharma shares in Q2 2026, an estimated $146K.
  • Royalty Pharma made up 0.02% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #487 holding.
  • Investment Management Corp of Ontario (IMCO) first reported a position in Royalty Pharma in Q4 2023 and has held it in 10 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.